Acadia Pharmaceuticals buy Bank of America Co.
Start price
30.06.26
/
50%
€22.15
Target price
30.06.27
€26.32
Performance (%)
0.86%
Price
27.07.26
€22.34
Summary
This prediction is currently active. Since the start of the prediction for Acadia Pharmaceuticals the price has only changed by 0.86%. This prediction currently runs until 30.06.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | 1.684% |
| iShares Core DAX® | 2.992% |
| iShares Nasdaq 100 | -1.584% |
| iShares Nikkei 225® | -2.254% |
| iShares S&P 500 | -0.009% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) had its price target raised by Bank of America Corporation from $29.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.04
25.03.26
25.03.26
€24.99
25.03.27
25.03.27
17.33%
27.07.26
27.07.26
